Despite anti-retroviral therapy (ART), human immunodeficiency virus-1 (HIV)-related
pulmonary disease continues to be a major cause of morbidity and mortality for people living …

Tuberculosis remains a major health threat in much of the world. New vaccines against
Mycobacterium tuberculosis are essential for preventing infection, disease, and …

An α-d-glucan (RR1) composed of (1→ 4) linked back bone and (1→ 6) linked branches
with a molecular mass of> 550 kDa and exhibiting unique immune stimulating properties is …

The acute inflammatory airway response is characterized by a time-dependent onset
followed by active resolution. Emerging evidence suggests that epithelial cells of the …

A silicose, a mais prevalente das pneumoconioses, é provocada pela inalação de partículas
de sílica cristalina. Indivíduos expostos à sílica, com ou sem silicose, apresentam risco …

Background Current treatment regimens for pulmonary tuberculosis require at least 6
months of therapy. Immune adjuvant therapy with recombinant interferon-γ1b (rIFN-γb) may …

Animal Lectins: Form, Function and Clinical Applications presents up-to-date knowledge of
animal lectins. Detailed descriptions on biological activities, tissue and/or subcellular …

Collectins are collagen-containing C-type (calcium-dependent) lectins which are important
pathogen pattern recognising innate immune molecules. Their primary structure is …

Smoking increases susceptibility to becoming infected with and developing tuberculosis.
Among the components of cigarette smoke, nicotine has been identified as the main …

Mycobacterium tuberculosis (Mtb), the etiologic agent of tuberculosis (TB), is recognized by
a number of pathogen recognition receptors (PRRs), either soluble or predominantly …